BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 18625444)

  • 1. Autoimmune mechanisms in type 1 diabetes.
    Knip M; Siljander H
    Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
    J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
    Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM
    Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
    Thivolet C; Khallouf E
    Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in type 1 diabetes.
    Taplin CE; Barker JM
    Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of CTLA-4 polymorphism and human leukocyte antigen genotype for the induction of diabetes-associated cytokine response in healthy school children.
    Jonson CO; Lernmark A; Ludvigsson J; Rutledge EA; Hinkkanen A; Faresjö M
    Pediatr Diabetes; 2007 Aug; 8(4):185-92. PubMed ID: 17659059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
    Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity.
    Durinovic-Belló I; Boehm BO; Ziegler AG
    J Autoimmun; 2002 Feb; 18(1):55-66. PubMed ID: 11869047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.
    Waid DM; Wagner RJ; Putnam A; Vaitaitis GM; Pennock ND; Calverley DC; Gottlieb P; Wagner DH
    Clin Immunol; 2007 Aug; 124(2):138-48. PubMed ID: 17560173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.
    Aly TA; Ide A; Humphrey K; Barker JM; Steck A; Erlich HA; Yu L; Miao D; Redondo MJ; McFann K; Roberts CM; Babu SR; Norris JM; Eisenbarth GS; Rewers MJ
    J Autoimmun; 2005; 25 Suppl():40-5. PubMed ID: 16242305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
    Oling V; Reijonen H; Simell O; Knip M; Ilonen J
    Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The demonstration and specificity of autoreactive T-lymphocytes in type-1 diabetes].
    Lohmann T; Scherbaum WA
    Dtsch Med Wochenschr; 1997 Jun; 122(23):737-42. PubMed ID: 9229550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes.
    Faresjö MK; Vaarala O; Thuswaldner S; Ilonen J; Hinkkanen A; Ludvigsson J
    Diabetes Metab Res Rev; 2006; 22(6):462-70. PubMed ID: 16572494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
    Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
    J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men.
    Unger WW; Pinkse GG; Mulder-van der Kracht S; van der Slik AR; Kester MG; Ossendorp F; Drijfhout JW; Serreze DV; Roep BO
    Ann N Y Acad Sci; 2007 Apr; 1103():192-5. PubMed ID: 17376840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.
    Preda I; McEvoy RC; Lin M; Bona CA; Rapaport R; Brumeanu TD; Casares S
    Eur J Immunol; 2005 Sep; 35(9):2762-75. PubMed ID: 16106371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
    Sobel DO; Creswell K
    Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of multimer technologies in type 1 diabetes prediction strategies.
    Fierabracci A
    Diabetes Metab Res Rev; 2011 Mar; 27(3):216-29. PubMed ID: 21309048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.